Moderna's voluntary withdrawal of the filing stems from the FDA's request for vaccine efficacy data from a phase III study on ...

Let’s dig into the relative performance of Corcept (NASDAQ:CORT) and its peers as we unravel the now-completed Q1 branded ...

Pfizer will produce the drug, which targets lung and colorectal cancers, in the US and take a US$100 million stake in China’s ...

Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals ...

The U.S. FDA will offer feedback and other assistance to states that want to allow importation of prescription drugs from ...

China continues to be a source of innovation as Pfizer strikes biggest pact yet; HHS provides more info on Trump’s Most ...

South Korean vaccine maker SK Bioscience has secured a final court victory over US pharma major Pfizer in a long-running ...

Shares of prominent COVID-19 vaccine-makers Moderna MRNA, Pfizer PFE and BioNTech BNTX rose yesterday after the FDA issued new guidance for COVID-19 vaccine boosters. FDA’s New ...

The HHS issues more details on President Donald Trump's plans to lower U.S. drug prices through most-favored-nation drug ...

3SBio will grant Pfizer exclusive global rights, not including China, to develop, manufacture and commercialize SSGJ-707, a ...

Pfizer, on the other hand, with its improving growth prospects, rising estimates, cheaper valuation, and higher dividend ...